Clinical trials are an important component driving innovation and improvements in clinical care, yet rural populations have historically been underrepresented in clinical trials. As part of the new funding cycle, WVCTSI is focusing on increasing opportunities for investigators to lead and patients to participate in clinical trials.
To that end, the West Virginia Clinical and Translational Science Institute clinical trials initiative is being renamed WVCTSI Clinical Trials. More importantly, the WVCTSI Clinical Trials team will be expanding and enhancing service to investigators.
As the WVCTSI team relocates to a new space in the Erma Byrd Biomedical Research Facility at WVU Health Sciences later this year, the WVCTSI Clinical Trials team will also be relocating to the new space. This will allow investigators to conveniently visit one location for research support and assistance.
WVCTSI Clinical Trials will continue providing financial, regulatory and study coordination support for clinical researchers. Investigators will also have access to clinical research protocol development, specimen collection (including shipping/delivery to core/central lab), accounting support for contract budget negotiations, data collection and entry. In an effort to expand industry-sponsored clinical trials, an agreement has been executed with TriNetX to enhance the connection of interested investigators with potential clinical trials in their field of expertise.
Shelley Welch, RN, MSHS, CCRC, clinical research services manager, will lead the WVCTSI Clinical Trials team as part of the Clinical Research Resources and Facilities Core of the WVCTSI. Ms. Welch, who has over 14 years of clinical research experience in a variety of settings, including industry and academia, will focus on project management and trial execution.
WVCTSI is committed to a service-driven approach for clinical trial resource delivery, and looks forward to better supporting investigators all across the state.